Viewing nowCombinationCandesartan Cilexetil and Rosuvastatin Tablets 5/16 mg
Rosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202107089 · Approved 2021.10.25 · Insurance code 694003650
Treatment of hypertension and heart failure; improvement of dyslipidemia; inhibition of atherosclerosis and prevention of cardiovascular disease
This medication is suitable for patients using both Candesartan Cilexetil and Rosuvastatin simultaneously. Candesartan Cilexetil is used for the treatment of essential hypertension and in patients with heart failure with impaired left ventricular function who require additional treatment with ACE inhibitors or who cannot tolerate them. Rosuvastatin is mainly administered as an adjunct to diet for patients with hypercholesterolemia (including primary and familial) and combined dyslipidemia, and is also effective in patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. Additionally, it lowers blood cholesterol levels, delaying the progression of atherosclerosis, and reduces the risk of stroke, myocardial infarction, and revascularization procedures in patients at high risk for cardiovascular diseases. Therefore, this medication improves the management of hypertension, heart failure, and cardiovascular diseases associated with complex dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of 2 weeks or longer, up to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. 2. Elderly: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Adolescents and children aged 18 years and younger: Safety and efficacy have not been established. Adolescents and children aged 18 years and younger: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, if pregnancy is confirmed, it should be discontinued immediately. This medication should not be given to patients with certain liver diseases, severely impaired kidney function, muscle disease history, and genetically induced lactose intolerance. Caution should be exercised in the elderly, patients with hyperkalemia, and those with compromised liver function while using this medication, and regular blood tests should be conducted to monitor their condition if necessary. If symptoms such as muscle pain or weakness occur, consult a doctor immediately; if blood markers indicating muscle damage increase along with these symptoms, the medication should be stopped. This medication may affect liver function; therefore, liver enzyme levels should be checked before and during administration, and if abnormalities are found, treatment should be discontinued. There is a risk of excessively low blood pressure or worsening kidney function, so especially in patients with heart failure or renal impairment, blood pressure and kidney function should be monitored regularly during administration. There may be interactions with other medications, so if you are taking any other medications, you must inform your doctor or pharmacist. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and breastfeeding women should avoid taking it or discontinue breastfeeding. The safety and efficacy of this medication have not been established in children and is not recommended. In case of overdose, appropriate treatment is required depending on the symptoms, and as there is no specific antidote, symptom management and monitoring are crucial. Dizziness or lethargy may occur while taking this medication; therefore, caution is advised when driving or operating machinery. Keep this medication out of reach of children and do not transfer it to another container for safety.
Headache, nasopharyngitis, local infections, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, elevated blood glucose, decreased serum sodium, hand fractures, hypoglycemia, nephrolithiasis, cough, dizziness, orthostatic dizziness, milia, periodontitis, chest discomfort, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, nausea, elevated blood glucose, decreased serum sodium, hand fractures, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, dizziness, dysesthesia, dyspepsia, gastritis, tachycardia, palpitations, hyperglycemia, hypertriglyceridemia, hyperuricemia, nasal bleeding, anxiety, depression, somnolence, dyspnea, hematuria, increased sweating, blood and lymphatic system disorders, leukopenia, neutropenia, agranulocytosis, hypokalemia, hyponatremia, hypoglycemia, cerebral infarction, spondyloarthritis, musculoskeletal discomfort, pneumonia, femoral fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, wet cough, exacerbation of hypertension, unstable blood pressure, vertigo, orthostatic vertigo, adrenal insufficiency, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbances, decreased libido, forgetfulness, poor appetite, increased appetite, tinnitus, taste distortion, erectile dysfunction, constipation, abdominal pain, pancreatitis, angioedema, hypersensitivity reactions including angioedema, constipation, nausea, abdominal pain, diarrhea, jaundice, hepatitis, liver dysfunction, angioedema, swelling of the face, lips, tongue, pharynx, larynx, rhabdomyolysis, arthralgia, low back pain, renal impairment, acute renal failure, interstitial pneumonia, shock, syncope, loss of consciousness, hypotension, hypotension, myalgia, myopathy, myositis, immune-mediated necrotizing myopathy, increased CK, increased ALT, increased AST, weakness, joint pain, numbness, dysesthesia, chest discomfort, poor appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, headache, dizziness, cough, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbances, decreased libido, forgetfulness, poor appetite, increased appetite, tinnitus, taste distortion, erectile dysfunction, constipation, abdominal pain, pancreatitis, angioedema, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, depression, sleep disturbances, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.